BackLifecore Biomedical Overview

Lifecore Biomedical Long Term Debt

Latest long-term debt for LFCR: $150M.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$148.80M

Peer average

Loading

Lifecore Biomedical Long Term Debt History

Loading

Lifecore Biomedical vs. peers: Long Term Debt Comparison

Loading

Lifecore Biomedical Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Lifecore Biomedical (LFCR) FAQ

The latest long-term debt for LFCR is $150M as of March 2026. Investors often review this figure alongside Lifecore Biomedical's historical trend and sector peers before judging valuation or financial health.

A long-term debt figure of $150M for LFCR is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting LFCR's long-term debt ($150M), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Lifecore Biomedical's long-term debt against similar Materials names. You can also browse sector and industry screens on Stockcircle for a broader set of Materials companies and their key multiples and fundamentals.